View Only- RNA Genetic Testing in Hereditary Cancer Improves Variant Classification and Patient Management-RNA Genetic Testing MP4

Video Transcription

Video Summary

The video conference is titled "RNA Genetic Testing in Hereditary Cancer Improves Variant Classification in Patient Management." The conference is hosted by the University of Iowa and features Dr. John Burnett, a clinical geneticist, as the host. Dr. Burnett is joined by four presenters, Dr. Huma Rana, a geneticist at Dana-Farber Cancer Institute, and three genetic counselors, Sarah Neshed from Rutgers Cancer Institute, Deborah Collins from the University of Kansas Cancer Center, and John Lee from Cedars-Sinai Medical Center. The conference discusses the basics of RNA genetic testing and its role in variant detection and classification. The presenters review specific case examples of variant resolution with RNA genetic testing and discuss how this type of testing can impact patient management. The conference emphasizes the importance of RNA genetic testing in providing more precise and accurate classification of genetic variants, particularly variants of uncertain significance (VUS). The presenters explain how RNA genetic testing can lead to more informed and personalized management plans for patients with hereditary cancer syndromes. The conference is intended for educational purposes only and offers continuing medical education (CME) credits to attendees.

Keywords

RNA Genetic Testing

Hereditary Cancer

Variant Classification

Patient Management

University of Iowa

Dr. John Burnett

Dr. Huma Rana

Genetic Counselors

RNA Genetic Testing Impact